Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetics in melanoma.

Shy Stahl1, Eran Bar-Meir, Eitan Friedman

  • 1Department of Plastic and Reconstructive Surgery, Sheba Medical Center, Tel Hashomer, Israel.

The Israel Medical Association Journal : IMAJ
|December 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors influencing uptake of risk-reducing mastectomy among unaffected Israeli BRCA1/BRCA2 pathogenic variant carriers.

Familial cancer·2026
Same author

Hormone Therapy After Oophorectomy and Breast Cancer Risk in Women With BRCA Pathogenic Variant.

JAMA network open·2026
Same author

Revisiting low penetrance retinoblastoma: an integrated clinical, genetic, and bioinformatic analysis.

Human molecular genetics·2026
Same author

Damaging missense variants in innate immunity genes are associated with earlier age of breast cancer onset in <i>BRCA1</i> 185delAG carriers.

Journal of medical genetics·2026
Same author

Outcomes of multigene panel testing for hereditary cancer in two Israeli medical centers 2013-2024.

Cancer genetics·2026
Same author

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

European urology·2026

Genetic factors like CDKN2A and CDK4 mutations significantly increase familial melanoma risk. Other low penetrance genes also contribute to inherited predisposition for this deadly skin cancer.

Area of Science:

  • Oncology
  • Genetics
  • Dermatology

Background:

  • Melanoma is a deadly skin cancer with increasing incidence.
  • Family history and UV exposure are known risk factors.
  • Genetic predisposition plays a crucial role in melanoma development.

Purpose of the Study:

  • To identify genes associated with inherited melanoma risk.
  • To understand the genetic basis of familial melanoma.
  • To explore both high and low penetrance genes in melanoma pathogenesis.

Main Methods:

  • Review of genetic studies on familial melanoma.
  • Analysis of germline mutations in melanoma predisposition genes.
  • Identification of high penetrance genes (CDKN2A, CDK4) and low penetrance genes.

Related Experiment Videos

Main Results:

  • Germline mutations in CDKN2A and CDK4 are linked to autosomal dominant, high penetrance familial melanoma.
  • Mutations and polymorphisms in genes such as MC1R, EGF, GSTM1, CYP2D6, and VDR are associated with familial melanoma.
  • These findings highlight a complex genetic landscape in melanoma inheritance.

Conclusions:

  • Germline mutations in cell cycle regulators CDKN2A and CDK4 are key drivers of high-risk familial melanoma.
  • Multiple low penetrance genes also contribute to inherited susceptibility to melanoma.
  • Further research into these genetic factors is essential for understanding and managing melanoma risk.